Skip to main content
SpringerLink
Log in

D

  • Chapter
Therapielexikon Endokrinologie und Stoffwechselkrankheiten

  • 1604 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Benkert O, Hippius H (Hrsg) (2003) Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin Heidelberg New York

    Google Scholar 

  2. Beyreuther K, Einhäupl KM, Förstl H, Kurz A (2002) Demenzen. Thieme, Stuttgart

    Google Scholar 

  3. Tariot PN, Farlow MR, Grossber GT, Graham SM, McDonald S, Gergel I (2004) Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil — a randomized controlled trial. JAMA 291:317–324

    Article  PubMed  CAS  Google Scholar 

Literatur

  1. Holsboer F (2000) The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23:477–501

    Article  PubMed  CAS  Google Scholar 

  2. Keck ME, Holsboer F (2001) Hyperactivity of CRH neuronal circuits as a target for therapeutic interventions in affective disorders. Peptides 22:835–844

    Article  PubMed  CAS  Google Scholar 

  3. Künzel HE, Binder EB, Nickel T, Ising M, Fuchs B, Majer M, Pfennig A, Ernst G, Kern N, Schmid DA, Uhr M, Holsboer F, Modell S (2003) Pharmacological and nonpharmacological factors in-fluencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test. Neuropsychopharmacology 28:2169–2178

    PubMed  Google Scholar 

Literatur

  1. Ritz E, Orth SR (1999) Nephropathy in patients with type 2 diabetes mellitus. Review. N Engl J Med 341:1127–33

    Article  CAS  Google Scholar 

  2. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I; Collaborative Study Group (2001) Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345:851–60

    Article  PubMed  CAS  Google Scholar 

  3. Gde P, Vedel P, Larsen N, Jensen GVH, Parving HH, Pedersen O (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383–393

    Article  Google Scholar 

Literatur

  1. DCCTResearch Group (1998) The effect of intensive diabetes therapy on measures of autonomic nervous system function in the diabetes control and complications trial. Diabetologia 41:416–23

    Article  Google Scholar 

  2. Gde P, Vedel P, Larsen N, Jensen GVH, Parving HH, Pedersen O (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383–393

    Article  Google Scholar 

Literatur

  1. Aktinson MA, Eisenbarth GS (2001) Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358:221–29

    Article  Google Scholar 

  2. The Diabetes Control and Complication Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–86

    Article  Google Scholar 

  3. The Diabetes Control and Complication Trial Research Group (1996) Lifetime benefits and costs of intensive therapy as practised in the diabetes control and complication trial. JAMA 276:1409–15

    Article  Google Scholar 

Literatur

  1. Nationale Versorgungsleitlinie Diabetes mellitus Typ 2 (2002) http://www.leitlinien.de/versorgungsleitlinien/index/diabetes/pdf/nvldiabetes

    Google Scholar 

  2. UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854–65

    Article  Google Scholar 

  3. Gde P, Vedel P, Larsen N, Jensen GVH, Parving HH, Pedersen O (2003) Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes. N Engl J Med 348:383–393

    Article  Google Scholar 

Literatur

  1. Kjos SL, Buchanan TA (1999) Current Concepts: Gestational Diabetes Mellitus. N Engl J Med 341:1749–56

    Article  PubMed  CAS  Google Scholar 

  2. Berger W, Grimm JJ (1998) Betreuung schwangerer Diabetikerinnen aus internistischer Sicht. Gynäkologe 31:31–37

    Article  Google Scholar 

Literatur

  1. Armstrong DG, Lavery LA, Harkless LB (1998) Validation of a diabeticwound classification. Diabetes Care 21:855–59

    Article  PubMed  CAS  Google Scholar 

  2. Standl E, Stiegler H, Janka HU, Hillebrand B (2003) Das diabetische Fußsyndrom. In: Mehnert H, Standl E, Usadel KH, Häring HU (Hrsg) Diabetologie in Praxis und Klinik. Thieme, Stuttgart, S 579–605

    Google Scholar 

Literatur

  1. Simsek E, at al. (2003) Wolfram (DIDMOAD) syndrome: a multidisciplinary clinical study in nine Turkish patients and review of the literature. Acta Paediatr 92(1):55–61

    Article  PubMed  CAS  Google Scholar 

Literatur

  1. Kruse K, Dörr HG, Grüters A, Holl R, Kiess W, Sinnecker GH (1999) Pädiatrische Endokrinologie. Georg Thieme Verlag, Stuttgart

    Google Scholar 

Literatur

  1. Vallone D, Picetti R, Borrelli E (2000) Structure and function of dopamine receptors. Neurosci Biobehav Rev 24:125–132

    Article  PubMed  CAS  Google Scholar 

Literatur

  1. De Vijlder JJM, Vulsma T (2000) Hereditary metabolic disorders causing hypothyroidism. In: Braverman LE, Utiger RD (eds) The Thyroid: A Fundamental and Clinical Text, 8th edn. Lippincott Williams & Wilkins, Philadelphia, S 733–742

    Google Scholar 

  2. Foley TP (1985) Familial thyroid dyshormonogenesis. In: Delange F, Fisher DA, Malvaux P (eds) Pediatric Thyroidology. Karger, Basel, S 174–188

    Google Scholar 

  3. Medeiros-Neto G, Stanbury JB (1994) Inherited Disorders of the Thyroid System. CRC Press, Boca Raton

    Google Scholar 

Literatur

  1. Schoenau E, Rauch F (2002) Fibrous dysplasia. Horm Res 57(Suppl 2):79–82

    Article  PubMed  CAS  Google Scholar 

  2. Weinstein LS, Yu S, Warner DR, Liu J (2001) Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting. Endocr Rev 22:675–705

    Article  PubMed  CAS  Google Scholar 

Download references

Editor information

Editors and Affiliations

  1. Innere Medizin, Endokrinologie und Klinische Chemie, Max-Planck-Institut für Psychiatrie, Kraepelinstr. 2-10, 80804, München, Deutschland

    Günter K. Stalla

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

(2007). D. In: Stalla, G.K. (eds) Therapielexikon Endokrinologie und Stoffwechselkrankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-30033-5_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-30033-5_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-20937-9

  • Online ISBN: 978-3-540-30033-5

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation